Phase II evaluation of chlorozotocin in refractory multiple myeloma.
Publication
, Journal Article
Forman, WB; Cohen, HJ; Bartolucci, AA; Manning, G
Published in: Cancer Treat Rep
November 1984
Duke Scholars
Published In
Cancer Treat Rep
ISSN
0361-5960
Publication Date
November 1984
Volume
68
Issue
11
Start / End Page
1409 / 1410
Location
United States
Related Subject Headings
- Streptozocin
- Multiple Myeloma
- Humans
- Drug Evaluation
- Antineoplastic Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Forman, W. B., Cohen, H. J., Bartolucci, A. A., & Manning, G. (1984). Phase II evaluation of chlorozotocin in refractory multiple myeloma. Cancer Treat Rep, 68(11), 1409–1410.
Forman, W. B., H. J. Cohen, A. A. Bartolucci, and G. Manning. “Phase II evaluation of chlorozotocin in refractory multiple myeloma.” Cancer Treat Rep 68, no. 11 (November 1984): 1409–10.
Forman WB, Cohen HJ, Bartolucci AA, Manning G. Phase II evaluation of chlorozotocin in refractory multiple myeloma. Cancer Treat Rep. 1984 Nov;68(11):1409–10.
Forman, W. B., et al. “Phase II evaluation of chlorozotocin in refractory multiple myeloma.” Cancer Treat Rep, vol. 68, no. 11, Nov. 1984, pp. 1409–10.
Forman WB, Cohen HJ, Bartolucci AA, Manning G. Phase II evaluation of chlorozotocin in refractory multiple myeloma. Cancer Treat Rep. 1984 Nov;68(11):1409–1410.
Published In
Cancer Treat Rep
ISSN
0361-5960
Publication Date
November 1984
Volume
68
Issue
11
Start / End Page
1409 / 1410
Location
United States
Related Subject Headings
- Streptozocin
- Multiple Myeloma
- Humans
- Drug Evaluation
- Antineoplastic Agents